Current methods for gene delivery may result in limited viability and efficacy

Complexities of the immune system prevent discovery

Lack of complexity in lung-on chips causes issues in interaction simulations

Naive state of T cells can be unstable and limited in efficacy

Methods for immunity response research can be invasive and carry risks

State-of-the-art engineered immune tissues lack spatial and temporal capabilities

Manually reprogramming stem cells is inefficient and time-consuming

Current ex vivo organoid models are unable to recapitulate spatiotemporal patterning of immune cells